Business
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline
UTRECHT, The Netherlands and PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (“LAVA”) (NASDAQ: LVTX) today announced a reminder to LAVA shareholders related to the proposed transaction with XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA). On August 4, 2025, XOMA and LAVA announced they had entered into a share purchase agreement. More recently, on October 17, 2025, XOMA announced it had extended its offer (the “Offer”) to purchase all outstanding common shares of LAVA unt
About this update from Xoma Royalty Corporation
[{"type":"image","alt":"LAVA Therapeutics N.V.","displaySize":"","headline":null,"caption":"LAVA Therapeutics N.V.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":131,"url":"https://media.zenfs.com/en/globenewswire.com/f725959d472b71cfe8f52ec1611234dd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GNvCVXFRhhyxvuaDQ5INfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f725959d472b71cfe8f52ec1611234dd","width":300,"height":131}},"lazy":false},{"type":"text","content":"UTRECHT, The Netherlands and PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (“LAVA”) (NASDAQ: LVTX) today announced a reminder to LAVA shareholders related to the proposed transaction with XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA).","length":262,"tagName":"p"},{"type":"text","content":"On August 4, 2025, XOMA and LAVA announced they had entered into a share purchase agreement. More recently, on October 17, 2025, XOMA announced it had extended its offer (the “Offer”) to purchase all outstanding common shares of LAVA until one minute after 11:59 p.m., Eastern time, on November 12, 2025 (the “Expiration Time”).","length":328,"tagName":"p"},{"type":"text","content":"LAVA would like to remind LAVA shareholders to tender their shares prior to the Expiration Time. If less than the requisite percentage of the outstanding common shares of LAVA are tendered, the Offer cannot be completed at the Expiration Time.","length":243,"tagName":"p"},{"type":"text","content":"The LAVA Board unanimously recommends that LAVA shareholders tender their shares pursuant to the Offer.","length":103,"tagName":"p"},{"type":"text","content":"If a sufficient number of shares are not tendered and the Offer cannot be completed, your investment may be exposed to significant risks, including the following:","length":162,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Liquidation and Dissolution – if the Offer is not completed, the LAVA Board may conclude that liquidation and dissolution is the only alternative available to LAVA, and LAVA’s management estimates that the total liquidation proceeds to shareholders are likely to be significantly less than the Offer cash consideration. In a liquidation, distributions to shareholders may be delayed and paid over an uncertain timeframe, wit...